R.P. Hulse
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
Hulse, R.P.; Beazley-Long, N.; Hua, J.; Kennedy, H.; Prager, J.; Bevan, H.; Qiu, Y.; Fernandes, E.S.; Gammons, M.V.; Ballmer-Hofer, K.; Gittenberger de Groot, A.C.; Churchill, A.J.; Harper, S.J.; Brain, S.D.; Bates, D.O.; Donaldson, L.F.
Authors
N. Beazley-Long
J. Hua
H. Kennedy
J. Prager
H. Bevan
Y. Qiu
E.S. Fernandes
M.V. Gammons
K. Ballmer-Hofer
A.C. Gittenberger de Groot
A.J. Churchill
S.J. Harper
S.D. Brain
DAVID BATES David.Bates@nottingham.ac.uk
Professor of Oncology
L.F. Donaldson
Abstract
Vascular endothelial growth factor-A (VEGF-A) is best known as a key regulator of the formation of new blood vessels. Neutralization of VEGF-A with anti-VEGF therapy e.g. bevacizumab, can be painful, and this is hypothesized to result from a loss of VEGF-A-mediated neuroprotection. The multiple vegf-a gene products consist of two alternatively spliced families, typified by VEGF-A165a and VEGF A165b (both contain 165 amino acids), both of which are neuroprotective. Under pathological conditions, such as in inflammation and cancer, the proangiogenic VEGF-A165a is upregulated and predominates over the VEGF-A165b isoform.
We show here that in rats and mice VEGF-A165a and VEGF-A165b have opposing effects on pain, and that blocking the proximal splicing event – leading to the preferential expression of VEGF-A165b over VEGF165a – prevents pain in vivo. VEGF-A165a sensitizes peripheral nociceptive neurons through actions on VEGFR2 and a TRPV1-dependent mechanism, thus enhancing nociceptive signaling. VEGF-A165b blocks the effect of VEGF-A165a.
After nerve injury, the endogenous balance of VEGF-A isoforms switches to greater expression of VEGF-Axxxa compared to VEGF-Axxxb, through an SRPK1-dependent pre-mRNA splicing mechanism. Pharmacological inhibition of SRPK1 after traumatic nerve injury selectively reduced VEGF-Axxxa expression and reversed associated neuropathic pain. Exogenous VEGF-A165b also ameliorated neuropathic pain.
We conclude that the relative levels of alternatively spliced VEGF-A isoforms are critical for pain modulation under both normal conditions and in sensory neuropathy. Altering VEGF-Axxxa/VEGF-Axxxb balance by targeting alternative RNA splicing may be a new analgesic strategy.
Citation
Hulse, R., Beazley-Long, N., Hua, J., Kennedy, H., Prager, J., Bevan, H., …Donaldson, L. (2014). Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiology of Disease, 71, 245-259. https://doi.org/10.1016/j.nbd.2014.08.012
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 6, 2014 |
Online Publication Date | Aug 21, 2014 |
Publication Date | 2014-11 |
Deposit Date | Jan 22, 2018 |
Publicly Available Date | Mar 29, 2024 |
Print ISSN | 0969-9961 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 71 |
Pages | 245-259 |
DOI | https://doi.org/10.1016/j.nbd.2014.08.012 |
Keywords | Vascular endothelial growth factor A; Alternative mRNA splicing; Neuropathy; Nociceptors |
Public URL | https://nottingham-repository.worktribe.com/output/1104991 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0969996114002435?via%3Dihub |
PMID | 00034254 |
Files
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
(2.5 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/3.0/
You might also like
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
(2023)
Journal Article
Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search